D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$516M |
| 2 |
Estee Lauder
EL
|
+$487M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
Nike
NKE
|
+$252M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$584M |
| 2 |
Tesla
TSLA
|
+$483M |
| 3 |
NVIDIA
NVDA
|
+$444M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
T-Mobile US
TMUS
|
+$296M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.67% |
| 2 | Consumer Discretionary | 9.3% |
| 3 | Healthcare | 7.82% |
| 4 | Financials | 5.66% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
AZZ Inc
AZZ
$4.46B
| $758K | ﹤0.01% |
16,625
-50,093
| -75% | -$2.29M |
|
3102
Virgin Galactic
SPCE
$326M
| $757K | ﹤0.01% |
21,038
-638
| -3% | -$38K |
|
3103
PUT
United Natural Foods
UNFI
$2.97B
| $756K | ﹤0.01% |
53,500
-27,500
| -34% | -$538K |
|
3104
CALL
Herbalife
HLF
$1.26B
| $755K | ﹤0.01% |
54,000
-5,500
| -9% | -$83.2K |
|
|
SII
3105
Sprott
SII
$2.69B
| $753K | ﹤0.01% |
24,700
-7,100
| -22% | -$233K |
|
3106
Zentalis Pharmaceuticals
ZNTL
$320M
| $751K | ﹤0.01% |
+37,439
| New | +$950K |
|
3107
W.P. Carey
WPC
$17B
| $749K | ﹤0.01% |
14,136
-63,688
| -82% | -$4.08M |
|
3108
Vertex
VERX
$2.05B
| $743K | ﹤0.01% |
32,147
-85,390
| -73% | -$1.76M |
|
3109
S&P Global
SPGI
$130B
| $740K | ﹤0.01% |
2,026
+1,307
| +182% | +$514K |
|
3110
Motorcar Parts of America
MPAA
$264M
| $739K | ﹤0.01% |
91,292
+3,426
| +4% | +$28.3K |
|
3111
Mirum Pharmaceuticals
MIRM
$6.97B
| $737K | ﹤0.01% |
+23,324
| New | +$639K |
|
3112
Bumble
BMBL
$385M
| $737K | ﹤0.01% |
49,396
-99,855
| -67% | -$1.69M |
|
3113
Columbia Financial
CLBK
$1.13B
| $737K | ﹤0.01% |
46,884
-3,702
| -7% | -$63.7K |
|
|
MARX
3114
DELISTED
Mars Acquisition Corp. Ordinary Shares
MARX
| $736K | ﹤0.01% |
70,000
| – | – |
|
3115
eGain
EGAN
$187M
| $736K | ﹤0.01% |
120,005
+28,512
| +31% | +$192K |
|
3116
Federal Agricultural Mortgage
AGM
$2.27B
| $735K | ﹤0.01% |
4,765
-7,850
| -62% | -$1.27M |
|
3117
Regenxbio
RGNX
$620M
| $735K | ﹤0.01% |
+44,628
| New | +$809K |
|
3118
PUT
Vermilion Energy
VET
$1.62B
| $732K | ﹤0.01% |
50,000
-70,000
| -58% | -$985K |
|
3119
Main Street Capital
MAIN
$5B
| $731K | ﹤0.01% |
17,992
+3,879
| +27% | +$158K |
|
|
SUPV
3120
Grupo Supervielle
SUPV
$856M
| $730K | ﹤0.01% |
328,970
-47,930
| -13% | -$138K |
|
|
GTHX
3121
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $727K | ﹤0.01% |
505,082
-111,421
| -18% | -$216K |
|
3122
Astronics
ATRO
$3.47B
| $727K | ﹤0.01% |
54,976
-95,558
| -63% | -$1.44M |
|
3123
CALL
Metropolitan Bank Holding Corp
MCB
$1.13B
| $726K | ﹤0.01% |
20,000
-82,200
| -80% | -$3.36M |
|
|
BNY
3124
PUT
Bank of New York Mellon
BNY
$107B
| $725K | ﹤0.01% |
+17,000
| New | +$757K |
|
3125
CGI
GIB
$14.6B
| $720K | ﹤0.01% |
7,300
-6,865
| -48% | -$701K |
|
Similar funds
D.E. Shaw & Co's Q3 2023 Portfolio in Review
As of Q3 2023, D.E. Shaw & Co held 4,689 positions worth $95.8B, down 2.2% from $97.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $2.99B in Q3 2023, closing 473 positions and reducing 1,535 holdings. Its most notable exit was State Street Consumer Staples Select Sector SPDR ETF, an estimated $174M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in NiSource Inc. Series A Corporate Units worth $52.6M.
- D.E. Shaw & Co's largest Q3 2023 buy was NiSource Inc. Series A Corporate Units: 540,000 shares worth $52.6M.
- D.E. Shaw & Co added most to Amazon in Q3 2023, an estimated $516M increase.
- D.E. Shaw & Co's biggest Q3 2023 reduction was Walmart Inc, cutting an estimated $584M.
- D.E. Shaw & Co fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2023, selling an estimated $174M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $95.8B portfolio in Q3 2023.
- D.E. Shaw & Co opened 482 new positions and closed 473 in Q3 2023.
- D.E. Shaw & Co's portfolio value fell 2.2% quarter-over-quarter to $95.8B.
Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.